Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132480) titled 'A study of the effects and risks of ciprofol, a new anesthetic drug, in breast cancer patients undergoing surgery after chemotherapy' on Sept. 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Cancer Hospital of Shantou University Medical College
Condition:
Breast cancer requiring surgery after neoadjuvant chemotherapy
Intervention:
Propofol (P) group:Use of propofol for perioperative anesthesia induction and maintenance.
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-06-07
Target Sample Size: Propofol (P) group:40;Ciprofol (C) group:40;
Countrie...